introduct
report
result
activ
surveil
influenza
infect
hospit
patient
evalu
season
correl
temperatur
rainfal
data
method
studi
period
patient
test
respiratori
virus
rv
result
virusposit
sampl
human
rhinoviru
respiratori
syncyti
viru
howev
influenza
viru
flua
flub
age
sari
significantli
associ
influenza
flub
circul
higher
conclus
postepidem
period
influenza
remain
import
caus
hospit
sari
patient
influenza
virus
caus
season
infect
associ
morbid
mortal
recommend
treatment
influenza
neuraminidas
inhibitor
vaccin
might
best
choic
public
health
prevent
consid
complic
among
highrisk
patient
peak
time
influenzalik
ill
ili
vari
season
character
region
dispers
viru
import
introduc
prevent
measur
mani
influenza
subtyp
determin
presenc
specif
hemagglutinin
neuraminidas
subtyp
associ
pandem
episod
influenza
b
classifi
two
genet
antigen
distinct
lineag
victoria
yamagata
although
potenti
pandem
viru
influenza
b
often
caus
outbreak
human
character
clinic
pattern
intermedi
sever
howev
fatal
among
influenza
b
case
occur
especi
pediatr
popul
influenza
subtyp
influenza
b
lineag
detect
brazil
influenza
season
clinic
manifest
influenza
viru
infect
includ
fever
headach
myalgia
cough
sore
throat
sign
sever
includ
oxygen
satur
dyspnea
respiratori
discomfort
presenc
sever
diseas
set
diagnosi
sever
acut
respiratori
ill
sari
also
requir
notif
brazilian
health
system
emerg
influenza
virus
includ
v
subtyp
surveil
emerg
virus
import
includ
activ
passiv
surveil
system
goal
system
rapid
earli
identif
potenti
epidem
strain
prevent
spread
surveil
system
design
detect
trigger
possibl
hazard
public
health
provid
earli
warn
establish
measur
minim
risk
global
effect
studi
report
find
consecut
year
influenza
infect
activ
surveil
respiratori
viru
rv
investig
conduct
hospit
patient
evalu
influenza
season
region
correl
viru
circul
temperatur
rainfal
data
analyz
epidemiolog
clinic
impact
compar
sever
influenza
infect
respiratori
viru
orv
infect
crosssect
studi
approv
institut
ethic
review
board
perform
hospit
de
universidad
feder
hcufpr
southern
brazil
overal
patient
select
two
databas
first
group
includ
hospit
individu
underw
laboratori
test
rv
medic
chart
select
group
review
focus
epidemiolog
clinic
manifest
outcom
laboratori
find
sari
diagnosi
criteria
ii
second
group
includ
anoth
case
hospit
patient
hcufpr
previous
notifi
sari
epidemiolog
hospit
staff
epidemiolog
clinic
data
group
electron
retriev
sari
notif
system
sari
defin
influenzalik
ill
along
sign
sever
dyspnea
oxygen
satur
respiratori
discomfort
meteorolog
data
brazil
includ
monthli
averag
temperatur
rainfal
mm
januari
decemb
obtain
sistema
simepar
databas
curitiba
locat
southern
brazil
latitud
temper
climat
rv
detect
multiplex
revers
transcript
polymeras
chain
reaction
rtpcr
use
ace
detect
kit
seegen
inc
korea
accord
manufactur
protocol
kit
enabl
simultan
detect
multipl
rv
human
adenoviru
human
metapneumoviru
parainfluenza
virus
influenza
flua
influenza
b
flub
respiratori
syncyti
viru
rsva
rsvb
human
rhinoviru
type
b
hrv
ab
human
enteroviru
human
bocaviru
human
coronaviru
type
alfacoronavirus
betacoronavirus
influenza
subtyp
perform
use
realtim
rtpcr
rtrtpcr
accord
center
diseas
control
prevent
protocol
influenza
bposit
sampl
test
identifi
lineag
use
singl
onestep
rtrtpcr
previous
report
data
analyz
use
r
r
core
team
version
parametr
nonparametr
test
use
assess
differ
continu
variabl
normal
asymmetr
distribut
respect
fisher
exact
pearson
chisquar
test
use
assess
differ
categor
variabl
appropri
covari
examin
univari
analysi
determin
associ
influenza
rv
infect
p
includ
multivari
analysi
use
stepwis
condit
procedur
multivari
logist
regress
model
conduct
identifi
independ
predictor
consid
presenc
influenza
rv
infect
endpoint
verifi
qualiti
fit
goodnessoffit
use
hosmerlemeshow
test
qqplot
graph
show
good
fit
propos
model
data
pvalu
twotail
p
consid
statist
signific
overal
patient
virusposit
sampl
seen
tabl
influenza
viru
detect
sampl
includ
influenza
nine
influenza
b
commonli
detect
viru
hrv
case
viral
codetect
occur
case
posit
sampl
among
influenza
viru
infect
found
eight
codetect
mainli
hrv
compar
orv
lower
rate
codetect
among
influenza
case
whether
viral
coinfect
may
enhanc
pathogen
infect
requir
investig
overal
influenza
sampl
subtyp
seven
season
lineag
differenti
influenza
bposit
reveal
victorialik
figur
influenza
orv
predomin
children
age
year
repres
influenza
case
orv
case
median
age
differ
significantli
influenza
orv
case
year
respect
tabl
influenza
infect
affect
patient
age
year
popul
remain
suscept
viru
public
health
system
provid
vaccin
children
year
elderli
year
health
worker
patient
comorbid
addit
likelihood
influenza
infect
increas
proport
age
vaccin
statu
data
larg
amount
miss
inform
due
retrospect
natur
studi
patient
influenza
record
receiv
influenza
vaccin
last
year
find
emphas
need
expand
immun
coverag
highrisk
patient
patient
infect
receiv
vaccin
present
low
immun
respons
unlik
immedi
postpandem
year
reduct
antivir
use
patient
influenza
infect
observ
among
case
influenza
studi
influenzainfect
patient
show
case
fever
cough
myalgia
patient
infect
orv
tabl
even
though
influenza
infect
compris
total
case
rv
detect
studi
virus
repres
case
myalgia
furthermor
influenza
infect
tend
caus
sever
diseas
case
sari
howev
find
confirm
prospect
studi
higher
number
patient
total
case
studi
diagnos
sari
virusposit
posit
influenza
tabl
adjust
analysi
show
patient
older
sari
myalgia
increas
chanc
posit
result
influenza
therefor
older
patient
sari
diagnosi
treat
influenza
infect
laboratori
investig
complet
chest
xray
perform
posit
patient
show
abnorm
signific
alter
interstiti
pneumonia
pulmonari
consolid
mix
pattern
p
report
patient
infect
influenza
orv
respect
studi
neglect
analysi
xray
pattern
respiratori
tract
infect
caus
influenza
show
statist
relev
analysi
influenzainfect
patient
radiograph
find
either
consolid
mix
pattern
none
simultan
bacteri
detect
result
emphas
sever
tissu
damag
found
hospit
patient
pneumonia
caus
influenza
comparison
epidemiolog
clinic
characterist
report
studi
patient
influenza
viru
b
infect
reveal
statist
signific
result
differ
although
low
preval
influenza
b
viru
may
impair
assess
studi
aim
compar
clinic
present
influenza
patient
across
viru
type
subtypeslineag
report
diverg
result
howev
gener
despit
differ
age
distribut
clinic
ill
produc
differ
influenza
viru
type
subtyp
indistinguish
year
influenza
case
common
june
juli
studi
result
show
associ
influenza
rate
decreas
temperatur
figur
howev
unlik
previou
find
associ
observ
influenza
circul
rainfal
studi
period
studi
influenza
season
brazil
shown
distinct
pattern
viral
circul
northeast
region
influenza
circul
first
month
year
overlap
period
higher
humid
area
differ
circul
profil
due
climat
condit
region
impact
vaccin
effect
tropic
region
carri
period
subsequ
viral
circul
influenza
posit
among
sampl
found
similar
previou
report
howev
present
studi
test
larger
number
influenza
viru
sampl
subtyp
brazil
nonhomogen
distribut
influenza
subtyp
laboratori
surveil
data
southern
region
show
higher
frequenc
influenza
respect
northeastern
region
differ
climat
condit
circul
influenza
first
epidemiolog
week
ew
increas
detect
th
th
ew
lower
intens
occur
southeastern
southern
region
find
highlight
need
subtyp
influenza
sampl
distinct
region
improv
surveil
system
among
influenza
b
case
occur
reintroduct
victoria
lineag
observ
influenza
b
case
region
antigen
categor
victoria
lineag
year
predomin
circul
lineag
victorialik
variant
differ
select
vaccin
composit
viru
similar
yamagata
lineag
highlight
import
updat
inform
circul
virus
determin
vaccin
composit
find
emphas
import
public
vaccin
studi
circul
viru
strain
although
differ
statist
signific
rate
sever
case
among
influenza
b
case
higher
previous
report
recent
report
also
shown
similar
find
incid
sever
diseas
influenza
b
find
underscor
relev
influenza
b
infect
usual
associ
mild
diseas
studi
limit
retrospect
data
collect
may
contribut
loss
clinic
laboratori
inform
paramet
higher
rate
miss
data
vaccin
statu
radiograph
pattern
prospect
studi
involv
wider
period
time
would
improv
analysi
allow
evalu
season
influenza
b
case
conclus
influenza
infect
associ
season
sever
diseas
occur
commonli
older
patient
usual
nonimmun
popul
influenza
treatment
rate
increas
treatment
initi
earlier
especi
critic
ill
patient
increas
frequenc
influenza
b
infect
occur
probabl
due
mismatch
vaccin
circul
lineag
strengthen
surveil
system
within
institut
import
rapidli
identifi
circul
pathogen
present
risk
public
health
